|
|
|
|
|
|
°Àǽð£ |
Àå¼Ò |
Title |
Lecturer |
18:00~20:00 |
A room |
Bone - Recent advances in bone formation |
ÁÂÀå : ±è¿ë±â, Àӽ±æ |
How PTHrP regulates growth plate chondrocytes |
Kronenberg, Harvard Univ., USA |
Thyroid hormone regulation of IGF-1 action during pre-pubertal growth |
Mohan, Loma Linda Univ., USA |
Requirement of Osterix for adult bone formation and maintenance |
±èÁ¤Àº, °æºÏÀÇ´ë |
B room |
Neuroendocrine |
ÁÂÀå : ±è¼±¿ì |
Surgical strategies for the various types of pituitary adenomas |
Shozo Yamada, Toranomon Hospital, Japan |
Outcomes of the medical treatment of Acromegaly |
John Wass, Oxford Univ., UK |
20:00~ |
A room |
Àú³á ¸¸Âù |
|
|
|
|
|
°Àǽð£ |
Àå¼Ò |
Title |
Lecturer |
08:00~08:40 |
|
µî·Ï |
08:40~10:10 |
°ÀÇ½Ç 1 |
Updated Clinical Guideline |
ÁÂÀå : Á¶Á¤±¸, ¹é¼¼Çö |
Is A1C Useful for Diabetes Screening, Diagnosis in Clinical Practice? |
¿ÀÁö¿µ, ÀÌÈÀÇ´ë |
The Altered Adrenal Axis and Treatment With Glucocorticoids During Critical Illness |
±èÇý¼ø, °è¸íÀÇ´ë |
When HDL-Cholesterol Isn't Enough: Assessing Options for Managing Residual Risk |
±èÇüÁø, °üµ¿ÀÇ´ë |
°ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö I - ÁÁÀº¿¬±¸¸¦ À§ÇÑ ÀÇ·áÀ±¸®¿Í ¿¬±¸»ç¾÷ÀÇ ÀÌÇØ |
ÁÂÀå: À¯ÇüÁØ, ¹Úż± |
»ç¶÷À» ´ë»óÀ¸·Î ÇÏ´Â ¿¬±¸À±¸® |
±è¿ÁÁÖ, ¼¿ïÀÇ´ë ÀÇ»çÇб³½Ç |
¿¬±¸ÀÚÀÇ ±Û¾²±â À±¸® |
ÀÌÀÎÀç, ¼¿ï±³´ë |
³»ºÐºñ ¿¬±¸ÀÚ¸¦ À§ÇÑ ±¹Ã¥¿¬±¸ºñ ¼Ò°³ (¿¬±¸ºñ Á¾·ù¿Í °èȹ¼ ÀÛ¼º) |
ÀÌÀαÔ, °æºÏÀÇ´ë |
°ÀÇ½Ç 3 |
½Å°æ³»ºÐºñ¿¬±¸È¸ ½ÉÆ÷Áö¾ö |
ÁÂÀå : ¹éÀÚÇö |
Molecular targeted therapies for pituitary tumor |
±¸Ã¶·æ, ¿¬¼¼ÀÇ´ë |
Cushing¡¯s disease management after surgery |
±è»ó¿Ï, ¼¿ïÀÇ´ë |
Insulin status in acromegaly patients after sandostatin treatment |
±è¼º¿î, °æÈñÀÇ´ë |
10:10~10:30 |
|
Coffee Break |
10:30~12:00 |
°ÀÇ½Ç 1 |
Diabetes & Obesity I - Hepatic insulin resistance |
ÁÂÀå : ÀÌÇü¿ì, Â÷ºÀ¼ö |
Hepatic insulin resistance vs. Peripheral insulin resistance |
ÃÖö¼ö, °¡ÃµÀÇ´ë |
°£Á¶Á÷°ú ¸»ÃÊ Àν¶¸°°¨¼ö¼º Á¶Á÷ »çÀÌ communication |
ÀÌ´ëÈ£, Á¦ÁÖÀÇ´ë |
Hepatic insulin resistanceÀÇ Ä¡·á |
±èöÈñ, ¼øõÇâÀÇ´ë |
°ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö ¥± - ³»ºÐºñ Á¾¾çÀÇ Áø´Ü ¹× »õ·Î¿î Ä¡·áÁ¦ |
ÁÂÀå: ±èµ¿¼±, ¹ÚµµÁØ |
The Efficacy and safety of Pasireotide in Acromegaly and Cushing¡¯s syndrome |
±è¹Î¼±, ¿ï»êÀÇ´ë |
Medical treatment of pancreatic neuroendocrine tumor |
ÀåÈï¹®, ¿ï»êÀÇ´ë |
Novel B-raf kinase inhibitor °³¹ß |
½Éź¸, KIST |
°ÀÇ½Ç 3 |
½Å°æ³»ºÐºñ¿¬±¸È¸ ½ÉÆ÷Áö¾ö |
ÁÂÀå : ±è¼º¿¬ |
Multidisciplinary treatment after primary surgery in acromegaly |
Shozo Yamada. Toranomon Hospital, Tokyo, Japan |
New insights in the management of GH deficiency |
ÀÌÀºÁ÷, ¿¬¼¼ÀÇ´ë |
12:00~13:20 |
°ÀÇ½Ç 1 |
Luncheon Lecture ¥° |
ÁÂÀå: ÀÌÇöö |
Early Insulinization |
Á¤Àΰæ, °æÈñÀÇ´ë |
Luncheon Lecture ¥± |
ÁÂÀå: ±èÅÂÈ |
New Paradigm of Antihypertensive Treatment : Initial Combination Therapy |
À¯±ÔÇü, °Ç±¹ÀÇ´ë ½ÉÀå³»°ú |
13:20~13:30 |
°ÀÇ½Ç 1 |
°³È¸»ç |
´ëÇѳ»ºÐºñÇÐȸ ȸÀå ±è¿ë±â |
13:30~14:20 |
°ÀÇ½Ç 1 |
Plenary Lecture ¥° |
ÁÂÀå : ±è¼º¿î |
A review of current and future treatment strategies of Non-functioning pituitary adenomas |
John Wass, Oxford University, UK |
14:20~15:50 |
°ÀÇ½Ç 1 |
Bone I - Beyond bisphosphonates |
ÁÂÀå : °¹«ÀÏ, Á¤È£¿¬ |
Denosumab and other developing drugs |
L. Fitzpatrick (GSK, USA) |
Newly developing anabolic agents |
¹é±âÇö, °¡Å縯ÀÇ´ë |
Newly developing (reversible) anti-resorptives |
°íÁ¤¹Î, ¿ï»êÀÇ´ë |
°ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö¥² - Drug discovery and development in endocrinology and metabolism |
ÁÂÀå: ¹Ú°æ¼ö, ¼Û¹ÎÈ£ |
´ç´¢º´ Ä¡·áÁ¦ÀÇ ÃÖ±Ù °³¹ßµ¿Çâ |
õÇý°æ, °¡ÃµÀÇ´ë ¾à¸®Çб³½Ç |
Drug discovery in metabolic syndrome: focus on adipokines |
Gary Sweeny, Institut Pasteur Korea |
°æ±¸¿ë Ç÷´ç°ÇÏÁ¦ Á¦¹Ì±Û¸³Æ¾ÀÇ ¿¬±¸°³¹ß »ç·Ê |
ÀÓÇöÁÖ, LG»ý¸í°úÇÐ |
°ÀÇ½Ç 3 |
Health Care Professional Session I |
ÁÂÀå: ½É°Èñ, ÃÖ±ÝÈñ |
Àν¶¸° ÁÖ»ç¹ýÀÇ ½ÇÁ¦ |
±èÇý·Ã, µ¿»êÀÇ·á¿ø |
´ç´¢ÀÎÀÇ ¿îµ¿¿ä¹ý |
±è¿µ¼÷, ºÎ»ê ¸Þ¸®³î º´¿ø |
´ç´¢º´ÀÇ ÇÕº´Áõ °Ë»ç¹ý |
¼Ûº¹·Ê, ¼¿ï¼º¸ðº´¿ø |
15:50~16:10 |
|
Coffee Break (Æ÷½ºÅÍ ±¸¿¬ ¹ßÇ¥- º»°ü 1Ãþ) |
16:10~17:40 |
¹«±ÃÈȦ(º°°ü 2Ãþ) |
Health Care Professional Session ¥± |
ÁÂÀå: Ãְ湬, ¼ÕÁ¤¹Î |
Diet, Inflammation, and Diabetes |
¼ÕÁ¤¹Î, ¿ø±¤´ë ½ÄÇ°¿µ¾çÇаú |
³»ºÐºñÁúȯÇöȲ ¹× °ü·Ã¿äÀÎ : ±¹¹Î°Ç°¿µ¾çÁ¶»ç°á°ú¸¦ Áß½ÉÀ¸·Î |
¿À°æ¿ø, Áúº´°ü¸®º»ºÎ ¸¸¼ºº´Á¶»ç°ú |
´ç´¢ ¿¬±¸¿¡¼ÀÇ ¿µ¾çÀ¯ÀüüÀû Á¢±Ù |
äÁö¼÷, ¿¬¼¼´ëÇб³ ³ëÈ°úÇבּ¸¼Ò |
°ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö¥³ - U-healthcare in Endocrinology |
ÁÂÀå: ÀåÇÐö, ·ùÁØ¿À |
»óÈ£ ¿¬µ¿Àû À¯ÇコÄɾ ÀÌ¿ëÇÑ ´ç´¢º´ °ü¸® ¹× ½º¸¶Æ®ÄÉ¾î »ç¾÷ |
¹ÚÁß¿, ¿ï»êÀÇ´ë |
Application of ubiquitous healthcare service using new medical information system in elderly diabetic patients |
ÀÓ¼ö, ¼¿ïÀÇ´ë |
À¯Çコ ¼ºñ½º ÇöȲ ¹× À̽´ |
¾È½ÃÈÆ, ºñÆ®ÄÄÇ»ÅÍ |
Biosensors for U-Healthcare |
Á¤ºÀÇö, KRIBB |
°ÀÇ½Ç 3 |
Thyroid I - Graves ophthalmopathy |
ÁÂÀå : ÀÌ»ó¿ , ±Ã¼º¼ö |
º´ÀÎ ¹× ±âŸ ÃÖ½ÅÁö°ß |
Hiromatsu Yuji, Kurume Univ., JPN |
½ÇÇèÀû Ä¡·á |
À±Áø¼÷, ¿¬¼¼ÀÇ´ë |
¾È°ú ¼ö¼úÀû Á¢±Ù |
ÃÖÈñ¿µ, ºÎ»êÀÇ´ë |
17:40~ |
°ÀÇ½Ç 1 |
Welcome reception |
|
|
|
|
°Àǽð£ |
Àå¼Ò |
Title |
Lecturer |
07:30~08:00 |
°ÀÇ½Ç 1 |
Breakfast Lecture |
ÁÂÀå: ±è¼º¿î |
The role of DPP-4 inhibitors in individualized strategies to control diabetes |
Á¶¿µ¹Î, ¼¿ïÀÇ´ë |
08:00~08:30 |
|
µî·Ï |
08:30~10:00 |
°ÀÇ½Ç 1 |
Meet the Expert |
|
DM & Obesity |
¿ìÁ¤ÅÃ, °æÈñÀÇ´ë |
Adrenal |
ÃÖµ¿¼·, °í·ÁÀÇ´ë |
Endocrine Hypertension |
À̹®±Ô, ¼º±Õ°üÀÇ´ë |
°ÀÇ½Ç 2 |
Thyroid II - Thyroid cancer |
ÁÂÀå : Á¶º¸¿¬, ¼Û¿µ±â |
Epigenetic dysregulation in thyroid cancer |
Tetsuo Kondo, Yamanashi Univ., JPN |
(18)F-FDG Uptake and Biological Markers in Thyroid Cancer |
±èÀÎÁÖ, ºÎ»êÀÇ´ë |
°©»ó¼± ¾Ï¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¾ÏÀüÀÌ ¿¬±¸ ¸ðµ¨ ±¸Ãà |
±èÅ¿ë, ¿ï»êÀÇ´ë |
°ÀÇ½Ç 3 |
Bone II - Anabolic signals: Parathyroids and IGFs |
ÁÂÀå : ½ÅÂù¼ö, ÃÖÁ¦¿ë |
Role of Ephrins in the regulation of bone formation |
S. Mohan , Loma Linda Univ., USA |
PTH and SOST |
ÀÌÀ¯¹Ì, ¿¬¼¼ÀÇ´ë |
Hypoparathyroidism and GCMB |
À̽ÃÈÆ, °¡ÃµÀÇ´ë |
10:10~10:20 |
|
Coffee Break |
10:20~11:10 |
°ÀÇ½Ç 1 |
Plenary Lecture ¥± |
ÁÂÀå : Àӽ±æ |
Actions of PTH on bone |
H. Kronenberg (Harvard Univ., USA) |
11:10~12:40 |
°ÀÇ½Ç 1 |
Updated Clinical Guideline |
ÁÂÀå : Á¶¿ë¿í, ¼ÕÇö½Ä |
Guidelines on Management of Primary Aldosteronism Issued |
±è»ó¼ö, ºÎ»êÀÇ´ë |
Current Issues Guidelines on Hormone Therapy |
±è¼ºÈÆ, ¿ï»êÀÇ´ë »êºÎÀΰú |
Endocrine Emergencies - thyroid storm, myxedema coma, DKA, and adrenal crisis |
·ù¿ÁÇö, ÇѸ²ÀÇ´ë |
°ÀÇ½Ç 2 |
Diabetes & Obesity II - Stem cell therapy in diabetic vascular complications |
ÁÂÀå : À̸í½Ä, À±°ÇÈ£ |
Mesenchymal stem cell therapy for lower extremity ischemia |
±èº´¼ö, ¼¿ï°ø´ë |
Ç÷°ü³»ÇÇ Àü±¸¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á |
±Ç»ó¸ð, CHAÀÇ°úÇдëÇб³ |
Stem cell therapy in ischemic cardiovascular disease |
ÀÓµµ¼±, °í·ÁÀÇ´ë |
°ÀÇ½Ç 3 |
Vascular biology |
ÁÂÀå : ±èÀÎÁÖ, À¯¼øÁý |
Intravenous Endothelial-like Cells Differentiated from Mesenchymal Stem Cells Accelerate Reendothelialization in Balloon-injured Rat |
Ȳ±âö, ¿¬¼¼ÀÇ´ë |
Homing and differentiation of endothelial progenitor cell |
±Ç¿µ±Ù, ¿¬¼¼´ë |
Establishment of endothelial stem cells from embryonic stem cells |
°í±Ô¿µ, KAIST |
12:40~14:00 |
°ÀÇ½Ç 1 |
Luncheon Lecture ¥² |
ÁÂÀå: ±è±¤¿ø |
Tredaptive, Novel Approach for Comprehensive Lipid Management |
¹Úö¿µ, ¼º±Õ°üÀÇ´ë |
Luncheon Lecture ¥³ |
ÁÂÀå: ±èµÎ¸¸ |
Will ACCORD Trial Results Change Your BP and Lipid Goals for Diabetics? |
±è½Å°ï, °í·ÁÀÇ´ë |
14:00~14:30 |
°ÀÇ½Ç 1 |
Presidential Lecture |
°©»ó¼±¾ÏÀÇ Áø´Ü ¹× Ä¡·á¿¡¼ ÇÙÀÇÇÐÀÇ ÀÌ¿ë |
±è¿ë±â, ´ëÇѳ»ºÐºñÇÐȸ ȸÀå |
14:30~15:10 |
°ÀÇ½Ç 1 |
2010³âµµ ³²°îÇмú»ó ½Ã»ó ¹× ¹ßÇ¥ |
ÁÂÀå : ¹ÎÇå±â |
Emerging role of Autophagy in Pancreatic - cell Homeostasis and Diabetes |
À̸í½Ä, ¼º±Õ°üÀÇ´ë |
15:10~15:20 |
°ÀÇ½Ç 1 |
2010 ±¹³»/¿Ü Çмú»ó ½Ã»ó½Ä, ÇϹݱ⠱¹Á¦ÇÐȸ Áö¿ø±Ý ¼ö»óÀÚ ½Ã»ó½Ä |
15:20~15:50 |
°ÀÇ½Ç 1 |
Ư° |
ÁÂÀå : ¼Û¿µ±â |
°©»ó¼±°áÀýÀÇ Áø´Ü ¹× Ä¡·á°¡À̵å¶óÀÎ |
¿øÀڷº´¿ø ÀÌ°¡Èñ |
15:50~17:20 |
°ÀÇ½Ç 1 |
Meet the Expert |
Bone |
¹Î¿ë±â, ¼º±Õ°üÀÇ´ë |
Pituitary |
º¯µ¿¿ø, ¼øõÇâÀÇ´ë |
Thyroid |
¼Û¹ÎÈ£, Ãæ³²ÀÇ´ë |
°ÀÇ½Ç 2 |
Vascular imaging - Imaging of atherosclerosis |
ÁÂÀå : ±èµÎ¸¸, ÀÌÀºÁ÷ |
MRI imaging of atherosclerosis |
Çã¿ë¹Î, SIRIC |
Peptide Probe-Based Targeted Imaging of Atherosclerosis |
À̺´Çå, °æºÏÀÇ´ë |
CT imaging of atherosclerosis |
ÃÖº´¿í, ¿¬¼¼ÀÇ´ë |
°ÀÇ½Ç 3 |
Aging and endocrine change |
ÁÂÀå : ¿ìÁ¤ÅÃ, °í°æ¼ö |
Aging, sarcopenia and diabetes |
¹Ú¼®¿ø, CHAÀÇ°úÇдëÇб³ |
Aging and osteoporosis |
¿À±â¿ø, ¼º±Õ°üÀÇ´ë |
Aging and changes in somatotropic axis |
±èµ¿¼±, ÇѾçÀÇ´ë |
17:20~ |
°ÀÇ½Ç 1 |
Dinner Lecture |
ÁÂÀå: ±è¼º¿î |
What is the optimal treatment for obese type 2 DM patients after OAD? |
±è¼º·¡, °¡Å縯ÀÇ´ë |
Æóȸ»ç |
´ëÇѳ»ºÐºñÇÐȸ ÀÌ»çÀå Àӽ±æ |
|
|
|
|
°Àǽð£ |
Àå¼Ò |
Title |
Lecturer |
08:00~08:25 |
|
µî·Ï |
08:25~08:30 |
°ÀÇ½Ç 1 |
°³È¸»ç |
±è¿ë±â, ´ëÇѳ»ºÐºñÇÐȸ ȸÀå |
08:30~10:10 |
°ÀÇ½Ç 1 |
°ñ´Ù°øÁõÀÇ Áø·á |
ÁÂÀå : ±è¿ë±â, ´ë±¸½Ã ³»°ú°³¿øÀÇ ÇùÀÇȸ ȸÀå ¹Ú½ÃÈ |
08:30-08:50 |
1. °ñ´Ù°øÁõ Áø´Ü ±â±âÀÇ ÃÖ½ÅÁö°ß |
¾ç½Â¿À, µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø |
08:50-09:10 |
2. °ñ´Ù°øÁõ °ü·Ã °Ë»ç(°ñ´ë»çÁöÇ¥, Ä®½·, ºñŸ¹ÎD, È£¸£¸ó ¹× ±âŸ) |
¿À±â¿ø, ¼º±Õ°üÀÇ´ë |
09:10-09:30 |
3. °ñ´Ù°øÁõ Ä¡·á ¾àÁ¦ÀÇ ÃÖ½ÅÁö°ß |
±è´öÀ±, °æÈñÀÇ´ë |
09:30~09:50 |
4. °ñ´Ù°øÁõ ȯÀÚ Áø·á¿Í ¾àÁ¦ ó¹æ ½ÇÁ¦ Áõ·Ê |
Á¤À±¼®, ¾ÆÁÖÀÇ´ë |
09:50-10:10 |
ÁúÀÇ, ÀÀ´ä ¹× ÅäÀÇ(5ºÐ) |
|
10:10~10:30 |
|
Coffee Break |
10:30~12:30 |
°ÀÇ½Ç 1 |
°©»ó¼±Áúȯ(Ç×ÁøÁõ, ÀúÇÏÁõ, °©»ó¼±Á¾, °áÀý)ÀÇ Ä¡·á |
ÁÂÀå : ±Ã¼º¼ö, ±è¿ø¹è |
10:30-10:40 |
1. °©»ó¼± Ç÷¾×°Ë»ç ¼³¸í |
±èÅ¿ë, ¿ï»êÀÇ´ë |
10:40-10:50 |
2. Ç×ÁøÁõ Ä¡·á¿¡ ÇÊ¿äÇÑ Áö½Ä°ú Æ÷ÀÎÆ® |
±èº¸Çö, ºÎ»êÀÇ´ë |
10:50-11:00 |
3. ÀúÇÏÁõ Ä¡·á¿¡ ÇÊ¿äÇÑ Áö½Ä°ú Æ÷ÀÎÆ® |
½Åµ¿¿±, ¿¬¼¼ÀÇ´ë |
11:00-11:10 |
4. °©»ó¼±Á¾°ú °áÀý ȯÀÚ¸¦ Áø·áÇÒ ¶§ °¡Àå ÇÊ¿äÇÑ Áö½Ä |
ÀÓµ¿ÁØ, °¡Å縯ÀÇ´ë |
11:10-11:20 |
5. °©»ó¼±ÀÇ ÀüÇüÀûÀÎ ÃÊÀ½ÆÄ ¼Ò°ßµé |
ÃÖ¿µ½Ä, °í½ÅÀÇ´ë |
11:20-11:35 |
6. °©»ó¼±ÀÇ ¾î·Á¿î Áõ·Ê ÀÌÇØÇϱâ |
°È£Ã¶, Àü³²ÀÇ´ë |
11:35-12:30 |
ÁúÀÇ, ÀÀ´ä ¹× ÆгΠÅäÀÇ(55ºÐ) |
ÁÂÀå ¹× Æгθ®½ºÆ®: °»ç 6ÀÎ(ÁöÁ¤) |
12:30~13:30 |
°ÀÇ½Ç 1 |
Luncheon Lecture ¥´ |
|
|
13:30~15:00 |
°ÀÇ½Ç 1 |
´ç´¢º´ÀÇ Áø´Ü, Ç÷´çÁ¶Àý, Àν¶¸° Åõ¿©, ÇÕº´Áõ ¿¹¹æ |
ÁÂÀå : ÀÌÇü¿ì, ¼Û¿µµæ |
13:30-13:40 |
1. ´ç´¢º´ÀÇ ¿øÀÎÀû/ÀÓ»óÀû ºÐ·ù¿Í ÀÚ¿¬°æ°ú |
Ãְ湬, °í·ÁÀÇ´ë |
13:40-13:50 |
2. °øº¹/½ÄÈÄÇ÷´ç, ´çÈÇ÷»ö¼Ò ¹× Ç÷´çº¯µ¿(Glycemic excursion) |
±èÇüÁø, °üµ¿ÀÇ´ë |
13:50-14:00 |
3. DPP4¾ïÁ¦Á¦¿Í GLP-1 À¯»çÁ¦ ÃÖ½ÅÁö°ß |
±è°æ¾Æ, µ¿±¹ÀÇ´ë |
14:00-14:15 |
4. °æ±¸¿ë ¾àÁ¦ ½ÃÀÛ, ¼±ÅÃ, Ãß°¡, Á¶ÇÕ ¹× º¯°æ |
±èÀçÇö, ¼º±Õ°üÀÇ´ë |
14:15-14:30 |
5. Àν¶¸° ÁÖ»çÀÇ ½ÃÀÛ, ¼±ÅÃ, È°¿ë ¹× ÁÖÀÇÁ¡ |
³²È«¿ì, ±¹¸³Áß¾ÓÀÇ·á¿ø |
14:30~14:45 |
6. ½Å°æº´ÁõÀÇ Æò°¡¿Í °ü¸®¹æ¹ý ¹× ¾àÁ¦Ã³¹æ |
±è´ëÁß, ¾ÆÁÖÀÇ´ë |
14:45~15:00 |
7. ´ç´¢º´È¯ÀÚÀÇ °íÇ÷¾Ð°ú °íÁöÇ÷Áõ ¾àÁ¦Ã³¹æ |
±èÇý¼ø, °è¸íÀÇ´ë |
15:00~15:20 |
|
Coffee Break |
15:20~16:30 |
°ÀÇ½Ç 1 |
ÁúÀÇ, ÀÀ´ä ¹× ÆгΠÅäÀÇ (60ºÐ) |
ÁÂÀå ¹× Æгθ®½ºÆ®: °»ç 6ÀÎ(ÁöÁ¤) |
16:30~16:40 |
°ÀÇ½Ç 1 |
Æóȸ»ç |
Àӽ±æ, ´ëÇѳ»ºÐºñÇÐȸ ÀÌ»çÀå |
|
|